1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The dengue testing market is evolving rapidly as health systems worldwide seek advanced diagnostics to address rising dengue cases and support timely public health interventions. Innovation and resilience are central priorities for organizations responding to this dynamic environment.
Market Snapshot: Dengue Testing Market Growth Overview
The dengue testing market grew from USD 527.02 million in 2024 to USD 558.61 million in 2025. It is expected to continue growing at a CAGR of 5.77%, reaching USD 738.13 million by 2030. Market momentum is underpinned by the global drive towards rapid, accurate diagnostics, especially in regions with endemic transmission. Stakeholders recognize the critical role of both laboratory and point-of-care test formats in supporting clinical decisions and outbreak management. Healthcare providers and policy leaders are prioritizing efficient, scalable solutions in the face of changing disease burdens and regulatory landscapes.
Scope & Segmentation of the Dengue Testing Market
This report offers senior decision-makers a comprehensive understanding of market dimensions and growth levers shaping the competitive landscape. Segmentation is based on diverse criteria reflecting operational demands and regional needs:
- Test Types: Antibody tests (IgG and IgM formats), antigen tests (NS1 enzyme-linked immunosorbent assay and NS1 rapid tests), and molecular tests (conventional and real-time polymerase chain reaction).
- Technologies: Enzyme-linked immunosorbent assays, lateral flow immunoassays (colloidal gold and fluorescent types), microarray technologies, and polymerase chain reaction platforms.
- End Users: Clinics, diagnostic laboratories, hospitals, and research institutes.
- Product Types: Instruments such as thermal cyclers and readers, software solutions, and test kits.
- Settings: Central laboratories and decentralized point-of-care environments.
- Sample Types: Plasma, serum, and whole blood specimens.
- Regions: The Americas (including the United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (including major and emerging markets), and Asia-Pacific (including China, India, Japan, and others).
- Companies Analyzed: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, bioMérieux SA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Meridian Bioscience, Inc., and Chembio Diagnostics, Inc.
Key Takeaways for Strategic Decision-Making
- Growth in dengue testing is driven by continual innovation in assay technologies and digital tools, supporting public health surveillance and adaptable clinical workflows.
- Point-of-care solutions have expanded their footprint with improved sensitivity, offering rapid results critical for both urban outbreaks and decentralized care in resource-limited settings.
- Automated laboratory workflows built around microarray and real-time PCR are streamlining high-throughput testing and multiplexing, essential for larger hospital and research settings.
- Competitive advantage increasingly relies on integrating software, hardware, and consumables through unified service agreements, simplifying procurement and ongoing support for healthcare organizations.
- Collaborative partnerships and technology transfer agreements are fostering local production, which in turn supports resilience against global supply chain disruptions and regulatory changes.
- Segmentation insights highlight the need for flexible product portfolios tailored to varying infrastructure, throughput, and clinical requirements across end users and regions.
Tariff Impact: Navigating 2025 U.S. Trade Changes
With the introduction of new U.S. tariffs on imported dengue diagnostic reagents, test kits, and equipment in 2025, cost pressures have grown for laboratories and suppliers. The increase in input expenses has led organizations to adjust procurement strategies, deepen local sourcing efforts, and establish new alliances to safeguard operational continuity. Investment in domestic manufacturing and technology transfer is accelerating to build long-term resilience, though initial capital costs and ramp-up timelines may present challenges.
Methodology & Data Sources
This analysis draws on peer-reviewed literature, regulatory filings, and industry white papers, complemented by interviews with laboratory directors, assay developers, and public health officials. Secondary research included review of clinical guidelines and laboratory protocols. Regional perspectives were gathered from trade publications, government reports, and expert commentary. Rigorous cross-validation ensured accuracy and transparency of findings.
Dengue Testing Market: Why This Report Matters
- Empowers product innovators and healthcare executives to make informed, future-proof investment and procurement decisions.
- Delivers actionable insights on technology trends, regulatory impacts, and regional drivers that shape competitive positioning.
- Supports strategy development by identifying opportunities for supply chain resilience, digital integration, and end user engagement.
Conclusion
The evolving dengue testing market requires agile strategies as new technologies, regulatory frameworks, and global health trends reshape the field. Stakeholders positioned for adaptability and collaboration will help define the next phase of diagnostic innovation and public health readiness.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dengue Testing Market, by Test Type
8.1. Introduction
8.2. Antibody Test
8.2.1. Igg Antibody Test
8.2.2. Igm Antibody Test
8.3. Antigen Test
8.3.1. Ns1 Enzyme Linked Immunosorbent Assay
8.3.2. Ns1 Rapid Test
8.4. Molecular Test
8.4.1. Conventional Polymerase Chain Reaction
8.4.2. Real Time Polymerase Chain Reaction
9. Dengue Testing Market, by Technology
9.1. Introduction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Lateral Flow Immunoassay
9.3.1. Colloidal Gold Assay
9.3.2. Fluorescent Immunoassay
9.4. Microarray Technology
9.5. Polymerase Chain Reaction
9.5.1. Conventional Polymerase Chain Reaction
9.5.2. Real Time Polymerase Chain Reaction
10. Dengue Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Dengue Testing Market, by Product Type
11.1. Introduction
11.2. Instruments
11.2.1. Readers
11.2.2. Thermal Cyclers
11.3. Software Solutions
11.4. Test Kits
12. Dengue Testing Market, by Setting
12.1. Introduction
12.2. Central Laboratory
12.3. Point Of Care
13. Dengue Testing Market, by Sample Type
13.1. Introduction
13.2. Plasma
13.3. Serum
13.4. Whole Blood
14. Americas Dengue Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Dengue Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Dengue Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. F. Hoffmann-La Roche Ltd
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. Danaher Corporation
17.3.5. bioM9rieux SA
17.3.6. QIAGEN N.V.
17.3.7. Bio-Rad Laboratories, Inc.
17.3.8. Siemens Healthineers AG
17.3.9. Meridian Bioscience, Inc.
17.3.10. Chembio Diagnostics, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DENGUE TESTING MARKET MULTI-CURRENCY
FIGURE 2. DENGUE TESTING MARKET MULTI-LANGUAGE
FIGURE 3. DENGUE TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DENGUE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY IGG ANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY IGM ANTIBODY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DENGUE TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DENGUE TESTING MARKET SIZE, BY COLLOIDAL GOLD ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DENGUE TESTING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DENGUE TESTING MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DENGUE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DENGUE TESTING MARKET SIZE, BY READERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DENGUE TESTING MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DENGUE TESTING MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DENGUE TESTING MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DENGUE TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DENGUE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DENGUE TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DENGUE TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 77. CANADA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 78. CANADA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 79. CANADA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. CANADA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 81. CANADA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 82. CANADA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 86. CANADA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 89. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 90. MEXICO DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 91. MEXICO DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 150. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 151. GERMANY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. GERMANY DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 159. GERMANY DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 162. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 163. FRANCE DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 164. FRANCE DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. FRANCE DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 166. FRANCE DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 167. FRANCE DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 171. FRANCE DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 184. ITALY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 185. ITALY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 186. ITALY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 187. ITALY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 188. ITALY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. ITALY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 190. ITALY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 191. ITALY DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 194. ITALY DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 195. ITALY DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SPAIN DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 198. SPAIN DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 199. SPAIN DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 200. SPAIN DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SPAIN DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. SPAIN DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 203. SPAIN DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 207. SPAIN DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 244. DENMARK DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 246. DENMARK DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 247. DENMARK DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 248. DENMARK DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 250. DENMARK DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 251. DENMARK DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 255. DENMARK DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 268. QATAR DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 269. QATAR DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 270. QATAR DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 271. QATAR DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 272. QATAR DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. QATAR DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 274. QATAR DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 275. QATAR DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. QATAR DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. QATAR DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 278. QATAR DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 279. QATAR DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 280. FINLAND DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 282. FINLAND DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 283. FINLAND DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 284. FINLAND DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. FINLAND DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 286. FINLAND DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 287. FINLAND DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. FINLAND DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. FINLAND DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 291. FINLAND DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. EGYPT DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 317. EGYPT DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 318. EGYPT DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 319. EGYPT DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 320. EGYPT DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. EGYPT DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 322. EGYPT DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 323. EGYPT DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. EGYPT DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. EGYPT DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 326. EGYPT DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 327. EGYPT DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 328. TURKEY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 329. TURKEY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 330. TURKEY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 331. TURKEY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 332. TURKEY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. TURKEY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 334. TURKEY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 335. TURKEY DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. TURKEY DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. TURKEY DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 338. TURKEY DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 339. TURKEY DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL DENGUE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 352. NORWAY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 353. NORWAY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2030 (USD MILLION)
TABLE 354. NORWAY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2030 (USD MILLION)
TABLE 355. NORWAY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 356. NORWAY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 357. NORWAY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 358. NORWAY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 359. NORWAY DENGUE TESTING M
Samples
LOADING...
Companies Mentioned
The companies profiled in this Dengue Testing market report include:- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- bioM9rieux SA
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Meridian Bioscience, Inc.
- Chembio Diagnostics, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | May 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 558.61 Million |
| Forecasted Market Value ( USD | $ 738.13 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
